CAS 151581-24-7

4H-1-Benzopyran-2-carboxylicacid,7-[[(1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[(R)-hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadien-1-yl]thio]-4-oxo-

Description:

The chemical substance known as 4H-1-Benzopyran-2-carboxylic acid, 7-[[1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[(R)-hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadien-1-yl]thio]-4-oxo- is a complex organic compound characterized by its multi-functional groups and structural features. It contains a benzopyran core, which is a fused ring system that contributes to its potential biological activity. The presence of a carboxylic acid group suggests acidic properties, while the various substituents, including hydroxy, acetyl, and trifluoromethyl groups, indicate potential for diverse chemical reactivity and interactions. This compound may exhibit significant pharmacological properties, making it of interest in medicinal chemistry. Its intricate structure implies that it could participate in various biochemical pathways, possibly influencing enzyme activity or receptor interactions. The CAS number 151581-24-7 uniquely identifies this substance in chemical databases, facilitating research and regulatory considerations. Overall, this compound's unique characteristics position it as a candidate for further investigation in drug development and other applications.

Formula: C₃₈H₃₇F₃O₈S

Synonyms:

• 4H-1-Benzopyran-2-carboxylicacid,7-[[(1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[(R)-hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadienyl]thio]-4-oxo-(9CI)
• 4H-1-Benzopyran-2-carboxylic acid, 7-[[9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadienyl]thio]-4-oxo-,[S-[R*,S*-(E,Z)]]-
• Iralukast

Iralukast

CAS: 151581-24-7

Iralukast is a leukotriene receptor antagonist that blocks the bronchoconstrictor response. It is used in the treatment of bronchial asthma, chronic obstructive pulmonary disease, and bowel diseases such as ulcerative colitis. Iralukast is not absorbed into the bloodstream and therefore does not inhibit the production of the inflammatory mediators that are responsible for these diseases. Iralukast binds to receptors on cells lining the airways, preventing activation of cells by leukotrienes, which are released by mast cells in response to an allergen or irritant. This binding prevents the release of inflammatory mediators from mast cells and reduces bronchial reactivity. Iralukast also has been shown to inhibit the enzyme activity of phospholipase A2 (PLA2), which has been implicated in inflammatory bowel disease.

Formula: C₃₈H₃₇F₃O₈S

Purity: Min. 95%

Molecular weight: 710.21612

Ref: 3D-FA104085

Iralukast (CGP 45715A)

CAS: 151581-24-7

Iralukast is a cysteinyl-leukotriene antagonist (CysLT) with a pKi of 7.8 for CysLT1.

Formula: C₃₈H₃₇F₃O₈S

Color and Shape: Solid

Molecular weight: 710.76

Ref: TM-T37016